Urcosimod is a lipid conjugated ChemR23 chemerin peptide agonist that is designed to reduce inflammation and pain in the eye.

The FDA is expected to decide on treatments for bullous pemphigoid, hereditary angioedema, HIV PrEP, ovarian cancer, and RSV.

The Food and Drug Administration (FDA) has cleared the Jewel ® Patch Wearable Cardioverter Defibrillator (Patch-WCD) for adult patients aged 18 years and older who are at risk for sudden cardiac ...

Polycystic ovarian syndrome (PCOS) is a complex disorder of metabolism, endocrine function, and the reproductive system that affects an estimated 1 in 10 ...

Nipocalimab-aahu is a human immunoglobulin G1 monoclonal antibody that binds with high affinity to the neonatal Fc receptor, resulting in the reduction of circulating IgG levels.

Outbreak mainly affected members of communities with low measles vaccination coverage in New Mexico, Oklahoma, and Texas.

Measles may reestablish endemicity, with an estimated 851,300 cases over 25 years at current vaccination rates.

Combined use of SGLT2 inhibitors and GLP-1 receptor agonists also significantly increased the risk for falls. HealthDay News — Sodium-glucose cotransporter 2 (SGLT2) inhibitor use is an independent ...

HealthDay News — For patients with chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL), statin use is associated with improved survival, regardless of treatment employed, according ...

Children receiving multiple antibiotic courses between birth and age 2 years may have a higher risk for some chronic conditions.

INX-315 is an oral, investigational selective cyclin-dependent kinase 2 (CDK2) inhibitor. The designation was based on preclinical data as well as interim data from the ongoing phase 1/2 INX-315-01 ...

Although no total cost is listed, labor alone is expected to cost at least $20 million and digital ads could cost tens of millions ...